Responsibilities

• Lead development and execution of the global commercial strategy for KT-621 from late-stage development through launch and lifecycle management.
• Define the global product vision, positioning, differentiation, target patient segments, and value proposition.
• Lead global launch readiness planning and commercialization activities.
• Develop disease-state and product-specific marketing strategies and messaging.
• Partner closely with the Analytics & Insights function on competitive intelligence, market assessments, forecasting inputs, and customer research.
• Serve as the commercial lead within cross-functional development teams.
• Influence clinical development strategy, endpoint selection, and evidence-generation plans.
• Evaluate expansion opportunities across immunology indications.
• Build strong partnerships across Clinical Development, Medical Affairs, Market Access, Regulatory, Finance, and Executive Leadership

Requirements

• Advanced degree required (MBA, PharmD, PhD, MD, MPH, or equivalent)
• 15+ years of progressive pharmaceutical or biotechnology commercial experience spanning global and U.S. markets
• Significant experience in global marketing, commercial strategy, and launch planning
• Direct immunology experience required
• Direct atopic dermatitis experience required
• Asthma experience strongly preferred
• Demonstrated success leading products through late-stage development and US commercial launch
• Strong understanding of specialty physician markets, payer dynamics, and patient journeys

Preferred

• Strategic thinker with strong commercial acumen
• Exceptional communication and executive presence
• Proven ability to influence cross-functional teams
• Data-driven decision maker
• Strong team builder and talent developer